PT  - JOURNAL ARTICLE
AU  - Ya-li Zhou
AU  - Yao Tong
AU  - Yi-xiao Wang
AU  - Pei-quan Zhao
AU  - Zhao-yang Wang
TI  - A prospective, randomised, double-masked comparison of local anaesthetic agents for vitrectomy
AID  - 10.1136/bjophthalmol-2016-309780
DP  - 2017 Aug 01
TA  - British Journal of Ophthalmology
PG  - 1016--1021
VI  - 101
IP  - 8
4099  - http://bjo.bmj.com/content/101/8/1016.short
4100  - http://bjo.bmj.com/content/101/8/1016.full
SO  - Br J Ophthalmol2017 Aug 01; 101
AB  - Purpose To compare the intraoperative and postoperative clinical properties of 1% ropivacaine, 0.75% bupivacaine, 2% lidocaine and a mixture of 0.75% bupivacaine and 2% lidocaine (bupi+lido) administered for peribulbar anaesthesia during vitrectomy.Methods A total of 140 patients were randomly allocated to four groups. The time of onset of analgesia and akinesia was measured. The efficacy of anaesthesia, degree of postoperative pain and intraoperative and postoperative complications were recorded.Results The mean times of onset (±SD) of analgesia for the ropivacaine, bupivacaine, lidocaine and lido+bupi groups were 90.46±30.08, 94.83±40.72, 78.31±12.56 and 101.51±56.94 s, respectively (p=0.087). The mean times of onset (±SD) of akinesia for the ropivacaine, bupivacaine, lidocaine and lido+bupi groups were 138.89±62.65, 151.86±84.78, 122.66±49.35 and 141.54±62.69 s, respectively (p=0.323). No significant difference was observed in the number of patients who attained grade-5 anaesthesia in the four groups (p=0.966). The outcome of ordered logit analysis showed that the 1% ropivacaine resulted in a significantly lower degree of postoperative pain compared with the other three groups (p=0.017, p=0.001 and p=0.001, respectively). The incidence of postoperative subconjunctival haemorrhage was decreased in the ropivacaine group compared with the other three groups (p<0.001).Conclusions For peribulbar anaesthesia in vitrectomy, 1% ropivacaine alone provides an adequate intraoperative anaesthesia similar to that provided by the bupivacaine, lidocaine and lido+bupi solutions, as well as provides a better quality of postoperative analgesia and decreases postoperative subconjunctival haemorrhage.Trial registration number ChiCTR-IPR-16007876; Results.